| In ZINC since | Heavy atoms | Benign functionality |
|---|---|---|
| June 26th, 2008 | 30 | Yes |
Popular Name: DORSOMORPHIN DORSOMORPHIN
Find On: PubMed — Wikipedia — Google
CAS Numbers: 1062368-24-4 , 1219168-18-9 , 866405-64-3 , [1219168-18-9]
6-(4-(2-(Piperidin-1-yl)ethoxy)phenyl)-3-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidine
6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine
6-[4-[2-(1-PIPERIDINYL)ETHOXY]PHENYL]-3-(4-PYRIDINYL)-PYRAZOLO[1,5-A]PYRIMIDINE DIHYDROCHLORIDE
| Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
|---|---|---|---|---|---|---|---|---|---|---|
| Ref Reference (pH 7) | 3.94 | 12.57 | -44.33 | 1 | 6 | 1 | 57 | 400.506 | 6 | ↓ |
| Hi High (pH 8-9.5) | 3.94 | 10.36 | -10.49 | 0 | 6 | 0 | 56 | 399.498 | 6 | ↓ |
| Lo Low (pH 4.5-6) | 3.94 | 13.05 | -77.93 | 2 | 6 | 2 | 58 | 401.514 | 6 | ↓ |
| Note Type | Comments | Provided By |
|---|---|---|
| ALOGPS_SOLUBILITY | 1.48e-02 g/l | DrugBank-experimental |
| Target | AMPK | Selleck Chemicals |
| Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| AAKB1-1-E | AMP-activated Protein Kinase, Beta-1 Subunit (cluster #1 Of 1), Eukaryotic | Eukaryotes | 41 | 0.34 | Binding ≤ 10μM |
| AAKG1-1-E | AMP-activated Protein Kinase, Gamma-1 Subunit (cluster #1 Of 1), Eukaryotic | Eukaryotes | 41 | 0.34 | Binding ≤ 10μM |
| AAPK2-1-E | AMP-activated Protein Kinase, Alpha-2 Subunit (cluster #1 Of 1), Eukaryotic | Eukaryotes | 41 | 0.34 | Binding ≤ 10μM |
| BMP4-1-E | Bone Morphogenetic Protein 4 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 430 | 0.30 | Binding ≤ 10μM |
| EPHA2-1-E | Ephrin Type-A Receptor 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 11 | 0.37 | Binding ≤ 10μM |
| FLT3-1-E | Tyrosine-protein Kinase Receptor FLT3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1 | 0.42 | Binding ≤ 10μM |
| KS6A1-1-E | Ribosomal Protein S6 Kinase Alpha 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 210 | 0.31 | Binding ≤ 10μM |
| LCK-1-E | Tyrosine-protein Kinase LCK (cluster #1 Of 4), Eukaryotic | Eukaryotes | 16 | 0.36 | Binding ≤ 10μM |
| MKNK1-1-E | MAP Kinase-interacting Serine/threonine-protein Kinase MNK1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 11 | 0.37 | Binding ≤ 10μM |
| SRC-1-E | Tyrosine-protein Kinase SRC (cluster #1 Of 3), Eukaryotic | Eukaryotes | 2 | 0.41 | Binding ≤ 10μM |
| VGFR1-1-E | Vascular Endothelial Growth Factor Receptor 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 11 | 0.37 | Binding ≤ 10μM |
| VGFR2-1-E | Vascular Endothelial Growth Factor Receptor 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 4 | 0.39 | Binding ≤ 10μM |
| Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| AAPK2_HUMAN | P54646 | AMP-activated Protein Kinase, Alpha-2 Subunit, Human | 41 | 0.34 | Binding ≤ 1μM |
| AAKB1_HUMAN | Q9Y478 | AMP-activated Protein Kinase, Beta-1 Subunit, Human | 41 | 0.34 | Binding ≤ 1μM |
| AAKG1_HUMAN | P54619 | AMP-activated Protein Kinase, Gamma-1 Subunit, Human | 41 | 0.34 | Binding ≤ 1μM |
| BMP4_HUMAN | P12644 | Bone Morphogenetic Protein 4, Human | 430 | 0.30 | Binding ≤ 1μM |
| EPHA2_HUMAN | P29317 | Ephrin Type-A Receptor 2, Human | 11 | 0.37 | Binding ≤ 1μM |
| MKNK1_HUMAN | Q9BUB5 | MAP Kinase-interacting Serine/threonine-protein Kinase MNK1, Human | 11 | 0.37 | Binding ≤ 1μM |
| KS6A1_HUMAN | Q15418 | Ribosomal Protein S6 Kinase Alpha 1, Human | 210 | 0.31 | Binding ≤ 1μM |
| LCK_HUMAN | P06239 | Tyrosine-protein Kinase LCK, Human | 16 | 0.36 | Binding ≤ 1μM |
| FLT3_HUMAN | P36888 | Tyrosine-protein Kinase Receptor FLT3, Human | 1 | 0.42 | Binding ≤ 1μM |
| SRC_HUMAN | P12931 | Tyrosine-protein Kinase SRC, Human | 2 | 0.41 | Binding ≤ 1μM |
| VGFR1_HUMAN | P17948 | Vascular Endothelial Growth Factor Receptor 1, Human | 11 | 0.37 | Binding ≤ 1μM |
| VGFR2_HUMAN | P35968 | Vascular Endothelial Growth Factor Receptor 2, Human | 4 | 0.39 | Binding ≤ 1μM |
| AAPK2_HUMAN | P54646 | AMP-activated Protein Kinase, Alpha-2 Subunit, Human | 41 | 0.34 | Binding ≤ 10μM |
| AAKB1_HUMAN | Q9Y478 | AMP-activated Protein Kinase, Beta-1 Subunit, Human | 41 | 0.34 | Binding ≤ 10μM |
| AAKG1_HUMAN | P54619 | AMP-activated Protein Kinase, Gamma-1 Subunit, Human | 41 | 0.34 | Binding ≤ 10μM |
| BMP4_HUMAN | P12644 | Bone Morphogenetic Protein 4, Human | 430 | 0.30 | Binding ≤ 10μM |
| EPHA2_HUMAN | P29317 | Ephrin Type-A Receptor 2, Human | 11 | 0.37 | Binding ≤ 10μM |
| MKNK1_HUMAN | Q9BUB5 | MAP Kinase-interacting Serine/threonine-protein Kinase MNK1, Human | 11 | 0.37 | Binding ≤ 10μM |
| KS6A1_HUMAN | Q15418 | Ribosomal Protein S6 Kinase Alpha 1, Human | 210 | 0.31 | Binding ≤ 10μM |
| LCK_HUMAN | P06239 | Tyrosine-protein Kinase LCK, Human | 16 | 0.36 | Binding ≤ 10μM |
| FLT3_HUMAN | P36888 | Tyrosine-protein Kinase Receptor FLT3, Human | 1 | 0.42 | Binding ≤ 10μM |
| SRC_HUMAN | P12931 | Tyrosine-protein Kinase SRC, Human | 2 | 0.41 | Binding ≤ 10μM |
| VGFR1_HUMAN | P17948 | Vascular Endothelial Growth Factor Receptor 1, Human | 11 | 0.37 | Binding ≤ 10μM |
| VGFR2_HUMAN | P35968 | Vascular Endothelial Growth Factor Receptor 2, Human | 4 | 0.39 | Binding ≤ 10μM |
| Description | Species |
|---|---|
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | |
| AMPK inhibits chREBP transcriptional activation activity | |
| CD28 co-stimulation | |
| CD28 dependent PI3K/Akt signaling | |
| CD28 dependent Vav1 pathway | |
| Constitutive PI3K/AKT Signaling in Cancer | |
| CREB phosphorylation | |
| CREB phosphorylation through the activation of Ras | |
| CTLA4 inhibitory signaling | |
| DAP12 signaling | |
| Downstream TCR signaling | |
| EPH-ephrin mediated repulsion of cells | |
| EPH-Ephrin signaling | |
| EPHA-mediated growth cone collapse | |
| ERK/MAPK targets | |
| Gastrin-CREB signalling pathway via PKC and MAPK | |
| Generation of second messenger molecules | |
| GPVI-mediated activation cascade | |
| Import of palmitoyl-CoA into the mitochondrial matrix | |
| Integrin cell surface interactions | |
| Interleukin-2 signaling | |
| Molecules associated with elastic fibres | |
| Nef and signal transduction | |
| Nef Mediated CD4 Down-regulation | |
| Neurophilin interactions with VEGF and VEGFR | |
| PD-1 signaling | |
| PECAM1 interactions | |
| Phosphorylation of CD3 and TCR zeta chains | |
| PIP3 activates AKT signaling | |
| Recycling pathway of L1 | |
| Regulation of AMPK activity via LKB1 | |
| Regulation of KIT signaling | |
| Regulation of Rheb GTPase activity by AMPK | |
| RSK activation | |
| Senescence-Associated Secretory Phenotype (SASP) | |
| Signaling by ERBB2 | |
| Signaling by SCF-KIT | |
| Spry regulation of FGF signaling | |
| Translocation of GLUT4 to the plasma membrane | |
| Translocation of ZAP-70 to Immunological synapse | |
| VEGF binds to VEGFR leading to receptor dimerization | |
| VEGFA-VEGFR2 Pathway | |
| VEGFR2 mediated cell proliferation |
No pre-computed analogs available. Try a structural similarity search.